Cerebrolysin vs Selank
Both Cerebrolysin and Selank are used for cognitive. Here's how their evidence, dosing, and regulatory status actually compare.
Cerebrolysin
Evidence BCerebrolysin (porcine brain peptide complex)
A standardized mixture of low-molecular-weight peptides from porcine brain. Decades of stroke, dementia, and TBI trial data — modest but consistent cognitive recovery effects.
View full Cerebrolysin profile →Selank
Evidence BSelank (TP-7)
A synthetic analog of tuftsin with anxiolytic and nootropic properties. Modulates GABA and serotonin systems to reduce anxiety without sedation.
View full Selank profile →Side-by-Side
| Attribute | Cerebrolysin | Selank |
|---|---|---|
| Evidence Grade | B | B |
| FDA Status | Not FDA-approved in US — approved in 50+ countries for stroke, traumatic brain injury, and dementia | Not FDA-approved in US — approved in Russia as anxiolytic |
| Typical Dose | Trial range: 5–30 mL daily (intravenous infusion) | 200–400 mcg intranasal, evening |
| Clinics Indexed | 41 | 72 |
| Categories | cognitive, neuroprotection | cognitive, anxiety |
Key reported benefits — Cerebrolysin
- ✓Stroke recovery support
- ✓TBI rehabilitation
- ✓Cognitive function in dementia
Key reported benefits — Selank
- ✓Anxiety reduction
- ✓Stress resilience
- ✓Cognitive clarity
- ✓Immune modulation
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.